Cholangiocarcinoma is a rare and aggressive cancer that forms in the bile ducts, the thin tubes that carry digestive fluid from the liver to the small intestine. Understanding how this cancer is detected and diagnosed is an important first step in planning treatment and making informed decisions about care.

Introduction: Who Should Seek Diagnostic Testing

Diagnosing cholangiocarcinoma can be challenging because symptoms often don’t appear until the cancer has already advanced. Most people don’t experience any warning signs in the early stages of the disease. When symptoms do appear, they typically occur because the growing tumor has started to block a bile duct, preventing the normal flow of bile through the body.^[1]

You should seek medical attention if you develop certain warning signs that may indicate a problem with your bile ducts. The most common symptom is jaundice, which means your skin and the whites of your eyes turn yellow. This happens because bile cannot flow properly and builds up in your body. Other symptoms that should prompt you to see a doctor include dark-colored urine, light-colored or clay-colored stools, persistent itchy skin, unexplained weight loss, abdominal pain (especially on the right side under your ribs), fever, fatigue, nausea, and vomiting.^[2][4]

It’s important to understand that these symptoms can be caused by many conditions other than bile duct cancer. However, because cholangiocarcinoma is often diagnosed at an advanced stage, early evaluation is crucial. People who have certain risk factors may need closer monitoring even without symptoms. These risk factors include chronic liver diseases such as primary sclerosing cholangitis, bile duct cysts, chronic ulcerative colitis, Crohn’s disease, certain liver infections, and bile duct stones or infections.^[7]

Most people diagnosed with cholangiocarcinoma are around age 70, though the disease can occur at any age. The cancer is relatively rare, affecting about 8,000 people in the United States each year.^[2]

Classic Diagnostic Methods

When doctors suspect cholangiocarcinoma based on your symptoms and medical history, they use several different types of tests to confirm the diagnosis and understand how far the disease has spread. Because obtaining tissue samples from bile ducts can be difficult, diagnosis often relies on a combination of different imaging techniques and laboratory tests.^[3]

Blood Tests

Blood tests are typically among the first diagnostic tools your doctor will use. Liver function tests measure how well your liver is working and can provide important clues about what’s causing your symptoms. When bile ducts are blocked, certain substances build up in the blood, and these tests can detect those changes.^[10][20]

Another important blood test measures a substance called carbohydrate antigen 19-9, often shortened to CA 19-9. This is a protein that bile duct cancer cells tend to produce in large amounts. When CA 19-9 levels are elevated in your blood, it may suggest the presence of bile duct cancer. However, this test alone cannot confirm a diagnosis because CA 19-9 levels can also be high in people with other bile duct problems such as inflammation or blockage that aren’t caused by cancer. Despite this limitation, CA 19-9 testing is useful for assessing how severe the disease might be and for monitoring how well treatment is working over time.^[3][10][20]

Imaging Studies

Imaging tests create pictures of the inside of your body and are essential for identifying tumors in the bile ducts. Several different imaging techniques may be used, each providing unique information.

Computed tomography, commonly called a CT scan, uses X-rays taken from many different angles to create detailed cross-sectional images of your body. CT scans can show the size and location of tumors in the bile ducts and help doctors determine if cancer has spread to other organs such as the liver or nearby lymph nodes.^[6]

Magnetic resonance imaging, or MRI, uses powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues. MRI scans are particularly good at showing bile ducts and can help distinguish between different types of bile duct problems. A special type of MRI called magnetic resonance cholangiopancreatography focuses specifically on the bile ducts and pancreatic ducts.^[6]

Positron emission tomography, known as a PET scan, involves injecting a small amount of radioactive sugar into your bloodstream. Cancer cells absorb more of this sugar than normal cells do, so they show up as bright spots on the scan. PET scans are especially useful for determining if cholangiocarcinoma has spread to distant parts of the body.^[6]

Ultrasound uses sound waves to create images of organs and tissues. Regular ultrasound can be performed on the surface of your abdomen, but two specialized types of ultrasound are particularly valuable for diagnosing bile duct cancer. Endoscopic ultrasound involves passing a thin, flexible tube with an ultrasound device at its tip down your throat and into your digestive system, allowing the device to get very close to the bile ducts for clearer images. Laparoscopic ultrasound is performed during a surgical procedure, with the ultrasound device inserted through small incisions in your abdomen.^[6][10][20]

Specialized Procedures

Endoscopic retrograde cholangiopancreatography, abbreviated as ERCP, is both a diagnostic test and sometimes a treatment procedure. During ERCP, your doctor passes a thin, flexible tube equipped with a camera through your mouth, down your throat, through your stomach, and into the small intestine where the bile duct opens. A special dye is then injected through a small tube into the bile ducts, and X-rays are taken. The dye makes the bile ducts clearly visible on the X-rays, showing any blockages or abnormalities. During this procedure, doctors can also pass tiny tools through the tube to collect tissue samples for biopsy or to place a stent (a small tube that holds the bile duct open) to help relieve blockages.^[10][20]

A similar procedure called percutaneous transhepatic cholangiography takes X-ray images of the bile ducts by inserting a thin needle through the skin and into the liver. Dye is injected through this needle to make the bile ducts visible on X-rays. This procedure can also be used to place a stent if a bile duct is blocked.^[7][11]

Cholangiography is a general term for any imaging technique that visualizes the bile ducts using contrast dye and X-rays. Different types of cholangiography may be used depending on your specific situation.^[6]

Biopsy

A biopsy is the only definitive way to confirm that cancer is present. During a biopsy, a small sample of tissue is removed from the suspicious area and examined under a microscope by a specialist called a pathologist. The pathologist can identify cancer cells and determine what type of cancer is present, how abnormal the cells look, and whether cancer has spread to nearby tissues.^[6]

However, obtaining tissue from bile ducts can be technically challenging. Sometimes biopsies are performed during ERCP or endoscopic ultrasound procedures. In other cases, a needle may be inserted through the skin to reach the tumor. Because these procedures can lack sensitivity, meaning they don’t always find cancer even when it’s present, doctors may proceed with surgery based on imaging findings and clinical presentation even if a biopsy doesn’t confirm cancer, especially when all other evidence strongly suggests cholangiocarcinoma.^[3]

Once tissue is obtained, the pathology report typically takes about five to ten days. This report is an essential part of planning your treatment, as it provides detailed information about the cancer type and grade. You have the right to request a copy of your pathology report for your personal records.^[6]

Determining Cancer Stage

After cholangiocarcinoma is diagnosed, doctors perform additional tests to determine the stage of the cancer. Staging describes how large the tumor is, whether it has spread to lymph nodes, and whether it has spread to other organs in the body. This information is crucial because it guides treatment decisions. Cholangiocarcinoma stages range from stage I (the smallest, most localized tumors) to stage IV (cancer that has spread to distant parts of the body, also called metastatic cancer).^[6]

Unfortunately, almost 75 percent of people with cholangiocarcinoma have disease that has already spread beyond the bile ducts or has grown too large to be completely removed by surgery by the time they are diagnosed. This is why the cancer is considered aggressive and why early detection is so important.^[3]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or combinations of treatments to find better ways to help people with cholangiocarcinoma. To participate in a clinical trial, you must meet specific criteria that ensure the trial is appropriate for your particular situation and that researchers can accurately measure how well the treatment works.

Biomarker Testing and Molecular Profiling

After you receive a cholangiocarcinoma diagnosis, your doctor will likely order a specialized test called next-generation sequencing, or NGS. This type of test is also known as molecular profiling or biomarker testing. These terms all refer to examining a sample of your tumor to look for specific changes or abnormalities in the genes of cancer cells.^[8]

Cholangiocarcinoma can be caused by different types of abnormal gene changes. These changes may include gene mutations (errors in a single gene), gene amplifications (too many copies of a gene), or gene fusions (when parts of two different genes abnormally join together). One of the most important gene fusions in cholangiocarcinoma is called an FGFR2 fusion, which occurs when the FGFR2 gene abnormally joins with another gene. This fusion creates an abnormal protein that causes bile duct cells to grow and divide without stopping, leading to tumor growth. FGFR2 fusions are one of the most common gene abnormalities found in people with intrahepatic cholangiocarcinoma (cancer inside the liver).^[8]

Identifying which specific gene changes are driving your cancer is important because it helps doctors determine if you might benefit from targeted therapies. These are treatments designed to attack cancer cells with specific genetic abnormalities while causing less harm to normal cells. Many clinical trials for cholangiocarcinoma require that participants have tumors with particular genetic changes, such as FGFR2 fusions, before they can enroll.^[8]

It’s important to talk to your healthcare provider about biomarker testing as soon as possible after your diagnosis. The sooner this testing is completed, the sooner you and your doctor can identify all available treatment options, including clinical trials that might be appropriate for you.

Standard Tests for Trial Enrollment

Clinical trials typically require participants to meet certain health criteria before enrollment. This often includes having completed the standard diagnostic tests described earlier, such as imaging studies to determine the stage of cancer, blood tests to assess liver function, and biomarker testing to identify specific genetic characteristics of the tumor.

Many trials also require that participants have measurable disease, meaning tumors that can be seen on imaging scans and measured to determine if they shrink, stay the same, or grow during treatment. Some trials are designed specifically for people whose cancer has spread beyond the bile ducts, while others may focus on earlier stages of disease.

Your performance status, which is a measure of how well you can carry out daily activities, is another important factor for trial enrollment. Trials often require participants to be able to care for themselves and be active for at least half of their waking hours. Your doctor will assess this as part of determining whether a particular trial is appropriate for you.

Previous treatments you’ve received may also affect trial eligibility. Some trials are designed for people who have not yet received any treatment for their cholangiocarcinoma, while others specifically recruit people whose cancer has continued to grow despite previous treatment.

The specific requirements vary greatly from one clinical trial to another. Your oncology team can help you understand which trials you might qualify for based on your individual diagnostic test results and medical situation.